These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 675261)

  • 21. Evaluation of retinyl palmitate and cytarabine treatment in a slowly growing rat leukemia model.
    Wathne KO; Lie SO; Colly L
    In Vivo; 1988; 2(2):139-41. PubMed ID: 2979829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the effect of antifolics in mouse leukemia.
    Motycka K
    Natl Cancer Inst Monogr; 1971 Dec; 34():167-77. PubMed ID: 4110901
    [No Abstract]   [Full Text] [Related]  

  • 23. [A modified screening model for potential cancerostatics by i.v. application of L 1210 ascites cells (author's transl)].
    Fey F; Ring G
    Arch Geschwulstforsch; 1976; 46(6):461-70. PubMed ID: 999455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
    Skipper HE; Schabel FM
    Cancer Chemother Rep 3; 1972 May; 3(1):3-5. PubMed ID: 4340386
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
    Bohunickå E; Koza I; Ujhåzy V
    Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Fujimoto S; Tsukagoshi S; Taguchi T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):201-9. PubMed ID: 1899547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.
    Vadlamudi S; Krishna B; Reddy VV; Goldin A
    Cancer Res; 1973 Sep; 33(9):2014-9. PubMed ID: 4725366
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK; Chitnis MP; Embrey WM; Gregory EB
    Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of cyclocytidine derivatives.
    Hoshi A; Kanazawa F; Kuretani K; Kanai T; Kikugawa K
    Gan; 1973 Oct; 64(5):519-22. PubMed ID: 4769741
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of mouse hepatitis virus infection on combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; DeKoning TF; Nicholas JA; Kramer GD; Wilson D; Wallace TL; Collins MJ
    Lab Anim Sci; 1987 Feb; 37(1):41-4. PubMed ID: 3035278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents.
    Bradner WT; Pindell MH
    Cancer Res; 1966 Apr; 26(4 Pt 2):375-90. PubMed ID: 4223140
    [No Abstract]   [Full Text] [Related]  

  • 32. Properties of antileukaemic drugs.
    Brusamolino E
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
    Breistøl K; Balzarini J; Sandvold ML; Myhren F; Martinsen M; De Clercq E; Fodstad O
    Cancer Res; 1999 Jun; 59(12):2944-9. PubMed ID: 10383159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 35. Preclinical screening for drugs effective against 5-fluorouracil-resistant cells with a murine L5178Y cell line in vitro.
    Hill BT
    J Natl Cancer Inst; 1983 Aug; 71(2):335-40. PubMed ID: 6576190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of the kinetic parameters of tumor growth and an evaluation of the antitumor activity of chemotherapeutic preparations based on life expectancy].
    Konradov AA; Dronova LM; Erokhin VN; Belich EI; Korman DB
    Izv Akad Nauk SSSR Biol; 1982; (3):419-27. PubMed ID: 7096779
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 38. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytarabine.
    Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023
    [No Abstract]   [Full Text] [Related]  

  • 40. Relevance of in vitro tests for predicting responsiveness to antitumor agents.
    Kessel D
    Natl Cancer Inst Monogr; 1971 Dec; 34():138-43. PubMed ID: 4946578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.